Org.nr 985 012 059 2023 → 2024 Year-over-year analysis

NAVAMEDIC ASA: årsregnskap 2024 vs 2023

Grew 11% on revenue, slipped into loss

approved 2025-06-04; registry 2025-07-16; journal 2025 669373

Full company analysis · All year comparisons

What changed

Comparing Årsregnskap 2024 with 2023 for NAVAMEDIC ASA. Revenue 47.63m NOK → 52.80m NOK (+10.9%). Net result +3.30m NOK → -16.66m NOK. Equity 201.62m NOK → 177.21m NOK.

On the constructive side: revenue rose; operating result improved; owners injected capital. Pressures included: fell into a net loss; equity eroded; cash fell.

Also worth watching: payroll increased. All figures are taken from the published annual accounts for NAVAMEDIC ASA.

Scorecard

Revenue
47.63m NOK 52.80m NOK
+10.9%
Operating result
-33.66m NOK -17.75m NOK
+47.3%
Net result
+3.30m NOK -16.66m NOK
-604.3%
Equity
201.62m NOK 177.21m NOK
-12.1%
Cash
7.81m NOK 6.83m NOK
-12.6%
Total assets
552.65m NOK 512.33m NOK
-7.3%

What improved

  • ↑

    Revenue rose

    Operating income / revenue moved from 47.63m NOK to 52.80m NOK (+10.9% YoY). Calculated

  • ↑

    Operating result improved

    Operating result -33.66m NOK → -17.75m NOK (op. margin -70.7% → -33.6%). Calculated

  • ↑

    Owners injected capital

    Paid-in equity rose 205.42m NOK → 211.31m NOK (+5.89m NOK). Reported fact

What deteriorated

  • ↓

    Fell into a net loss

    Net result flipped from 3.30m NOK profit to a loss of 16.66m NOK. Calculated

  • ↓

    Equity eroded

    Book equity 201.62m NOK → 177.21m NOK (equity ratio 36.5% → 34.6%). Calculated

  • ↓

    Cash fell

    Bank deposits 7.81m NOK → 6.83m NOK (-12.6% YoY). Calculated

Things to notice

  • ·

    Payroll increased

    Salary cost 36.83m NOK → 40.17m NOK (77% → 76% of revenue). Calculated